Open AccessINHIBITION OF THE FACTOR XA (WITH RIVAROXABAN) SLOW DOWN PROGRESSION, PREVENTS COMPLICATION AND DECREASE MORTALITY IN CORONARY HEART DISEASE
Author(s) -
В. Н. Хирманов
Publication year - 2018
Publication title -
rossijskij kardiologičeskij žurnal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.141
H-Index - 14
eISSN - 2618-7620
pISSN - 1560-4071
DOI - 10.15829/1560-4071-2018-3-65-70
Subject(s) - medicine , rivaroxaban , antithrombotic , cardiology , anticoagulant , coronary heart disease , clinical trial , dose , coronary artery disease , heart failure , drug , pharmacology , warfarin , atrial fibrillation